Novavax

company in Gaithersburg, Maryland

NVAX Nasdaq ISIN US6700024010 SEC CIK 1000694 LEI 529900J4GJHPEPQ23205
Follow Novavax Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Revenue, last quarter $68.3M −3% vs same quarter last year
Net income −$31.4M +84.5% vs same quarter last year
EPS, diluted −$0.19 +84.8% vs same quarter last year
Operating cash flow −$94.2M −187.4% vs same quarter last year
Revenue by quarter
$88.3M
$666.7M
$239.2M
$70.4M
$147.1M
$139.5M
$56.7M
$68.3M
Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income15 fiscal years
  • Revenue
  • Net income
−$2B−$1B$0$1B$2BFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearRevenueNet income
FY25$1.1B$440.3M
FY24$682.2M−$187.5M
FY23$983.7M−$545.1M
FY22$2B−$657.9M
FY21$1.1B−$1.7B
FY20$475.6M−$418.3M
FY19$18.7M−$132.7M
FY18$34.3M−$184.7M
FY17$31.2M−$183.8M
FY16$15.4M−$280M
FY15$36.3M−$156.9M
FY14$30.7M−$82.9M
FY13$20.9M−$52M
FY12$22.1M−$28.5M
FY11$14.7M−$19.4M
MarginsShare of revenue
  • Gross margin
  • Operating margin
  • Net margin
−2000%−1500%−1000%−500%0%500%FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearGross marginOperating marginNet margin
FY2593.5%40.3%39.2%
FY2470.3%−36.5%−27.5%
FY2365.1%−57.6%−55.4%
FY2254.5%−32.5%−33.2%
FY21100%−147.1%−152.1%
FY20100%−87.6%−87.9%
FY19-−646.1%−711%
FY18-−507.2%−538.8%
FY17-−550.8%−589.5%
FY16-−1752.8%−1823.5%
FY15-−433.8%−432.9%
FY14-−273%−270.5%
FY13-−250.7%−248.5%
FY12-−134.4%−129.1%
FY11-−146.9%−131.8%
Free cash flowOperating cash flow minus capital expenditure
−$400M−$200M$0$200M$400MFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearFree cash flow
FY25-
FY24-
FY23-
FY22-
FY21$265.5M
FY20−$97.2M
FY19−$138.5M
FY18−$186.2M
FY17−$148.7M
FY16−$277M
FY15−$144.4M
FY14−$74.3M
FY13−$51.1M
FY12−$22.6M
FY11−$24.2M
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • Novavax
  • Healthcare median
−2000%−1500%−1000%−500%0%500%FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearNovavaxHealthcare median
FY2539.2%−30.6%
FY24−27.5%−47%
FY23−55.4%−58%
FY22−33.2%−80.4%
FY21−152.1%−71.9%
FY20−87.9%−62.2%
FY19−711%−46.3%
FY18−538.8%−49.6%
FY17−589.5%−45.9%
FY16−1823.5%−36%
FY15−432.9%−38.4%
FY14−270.5%−35.5%
FY13−248.5%−37.1%
FY12−129.1%−29.1%
FY11−131.8%−27.9%